Israel’s Sofwave Medical (see here previously) has received approval from Health Canada to commercialize Pure Impact™ utilizing PlyoPulse™ EMS (“Electric Muscle Stimulation”) technology in that region. The system already has US-FDA approval.
https://finance.yahoo.com/news/sofwave-medical-receives-marketing-clearance-123300406.html